Ethylestradiol: Difference between revisions
CSV import |
No edit summary |
||
| Line 33: | Line 33: | ||
{{Pharmacology-stub}} | {{Pharmacology-stub}} | ||
{{Environment-stub}} | {{Environment-stub}} | ||
<gallery> | <gallery> | ||
File:17-Ethylestradiol.svg|Ethylestradiol | File:17-Ethylestradiol.svg|Ethylestradiol | ||
</gallery> | </gallery> | ||
Latest revision as of 20:53, 16 March 2025
Ethylestradiol (EE), also spelled ethinylestradiol in some countries, is a synthetic estrogen used in various contraceptive methods, including combined oral contraceptive pills, transdermal patches, and vaginal rings. It is a derivative of estradiol, the major endogenous estrogen in humans. Ethylestradiol is highly potent and is used in much lower doses than naturally occurring estrogens.
Medical Uses[edit]
Ethylestradiol is primarily used in contraceptive methods to prevent pregnancy. It is often combined with a progestogen to inhibit ovulation, thicken cervical mucus to prevent sperm from reaching the egg, and thin the uterine lining to prevent implantation. Ethylestradiol is also used in menopausal hormone therapy to treat symptoms of menopause, such as hot flashes and vaginal atrophy, and in some cases of hypoestrogenism, acne, and menstrual disorders.
Pharmacology[edit]
Mechanism of Action[edit]
Ethylestradiol binds to and activates the estrogen receptor (ER), mimicking the effects of natural estrogens in the body. Its activation of ERs in various tissues leads to the transcription of genes involved in the development and maintenance of female reproductive tissues and secondary sexual characteristics.
Pharmacokinetics[edit]
After oral administration, ethylestradiol is rapidly absorbed from the gastrointestinal tract. It undergoes extensive first-pass metabolism in the liver, which can be affected by various factors, including genetic polymorphisms and liver function. Ethylestradiol is metabolized into less active metabolites, which are then excreted in urine and feces.
Adverse Effects[edit]
The use of ethylestradiol-containing contraceptives is associated with an increased risk of venous thromboembolism (VTE), myocardial infarction, stroke, and in rare cases, liver cancer. The risk of these adverse effects is influenced by the dose of ethylestradiol, the type of progestogen used in combination, and the user's underlying risk factors, such as smoking and age.
Contraindications[edit]
Ethylestradiol is contraindicated in individuals with a history of thrombotic events, hormone-sensitive cancers (e.g., breast cancer), uncontrolled hypertension, severe liver disease, and those who are pregnant. It should be used with caution in smokers over the age of 35 due to an increased risk of cardiovascular events.
Interactions[edit]
Ethylestradiol's effectiveness can be reduced by certain medications that induce liver enzymes, such as rifampicin, phenytoin, and St. John's Wort, leading to decreased estrogen levels and potential contraceptive failure. Conversely, some drugs can increase ethylestradiol levels, increasing the risk of adverse effects.
Society and Culture[edit]
Ethylestradiol has played a significant role in the development of hormonal contraception, contributing to women's reproductive autonomy. However, its use has also been a subject of debate due to the associated health risks and environmental impact, as traces of ethylestradiol have been found in water sources, potentially affecting wildlife.
Environmental Impact[edit]
Ethylestradiol is a persistent environmental pollutant. It has been detected in water bodies worldwide, primarily due to the excretion of contraceptive hormones by humans and improper disposal of medications. Its presence in the environment can disrupt the endocrine systems of aquatic organisms, leading to reproductive and developmental abnormalities.

This article is a environment-related stub. You can help WikiMD by expanding it!
-
Ethylestradiol
